Well-Defined mRNA Platform Processes & Collaboration Advanced a Novel Gene Therapy in Jeopardy
Learn how Vernal Bio changed the course of a stalled cancer gene therapy program, pairing proven mRNA platform methods with scientific flexibility and hands-on collaboration.
Innovator’s Challenges
- No in-house mRNA experience
- Lengthy timelines & high vendor costs
- Novel asset requiring customized science
Vernal’s Solutions
- End-to-end pDNA, mRNA & LNP expertise
- Formulated LNP payloads in 2 months—less than a quarter of competitor timelines
- Flexible problem-solving and a collaborative partnership
Vernal Bio delivered proof-of-concept material on budget and schedule by leveraging well-defined processes and scientific creativity, then negotiated GMP production in just over one month.
From Stalled To Scaled: How mRNA Saved an Innovator’s Program
